Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
University venture fund University of Tokyo Edge Capital (Utec) has co-led a $7.5m round for India-based biopharmaceutical business Bugworks Research, the Economic Times reported today. Venture firm Global Brain co-led the round, which also featured healthcare investment company Acquipharma. Founded in 2014, Bugworks Research hopes to commercialise new antibiotics to treat bacterial infections and lessen the impact of anti-microbial resistance to existing drugs. The company’s pipeline focuses on a gyrase-topoisomerase inhibitor currently undergoing phase 1 studies in an intravenous form, with an oral equivalent progressing toward the clinic. Utec had already led Bugworks’ $9m series A round in 2018 with contributions from Acquipharma, 3One4 Capital and unnamed angel investors.
Suono Bio, a US-based inflammatory-mediated disease drug delivery spinout of Massachusetts Institute of Technology (MIT), received an undisclosed sum on Tuesday from industrial product manufacturer NGK Spark Plug. The company’s co-founders include Giovanni Traverso and Robert Langer, both professors at…
